We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study

    A dose-escalation and expansion, phase 1/2 study (ClinicalTrials.gov, NCT04818333) was conducted to assess the novel antibody-drug conjugate...

    Ziming Li, Zhengbo Song, ... Shun Lu in Signal Transduction and Targeted Therapy
    Article Open access 15 July 2024
  2. YAP/TAZ interacts with RBM39 to confer resistance against indisulam

    The Hippo pathway and its downstream effectors, Yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ), are essential...

    Toshinori Ando, Kento Okamoto, ... Mikihito Kajiya in Oncogenesis
    Article Open access 15 July 2024
  3. PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC

    Elevated infiltration of tumor-associated macrophages (TAMs) drives tumor progression and correlates with poor prognosis for various tumor types. Our...

    **uqiong Chen, **g Zhou, ... Richeng Jiang in Oncogene
    Article 14 July 2024
  4. PHF6 suppresses self-renewal of leukemic stem cells in AML

    Acute myeloid leukemia is characterized by uncontrolled proliferation of self-renewing myeloid progenitors accompanied by a differentiation arrest....

    Sapana S. Jalnapurkar, Aishwarya S. Pawar, ... Vikram R. Paralkar in Leukemia
    Article Open access 14 July 2024
  5. Hemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems

    Hematopoietic stem cell transplantation (HCT) represents a curative treatment option for certain malignant and nonmalignant hematological diseases....

    Dimitrios A. Tsakiris, Eleni Gavriilaki, ... Sara C. Meyer in Bone Marrow Transplantation
    Article Open access 14 July 2024
  6. Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies

    With advancements in novel therapeutics, it is unclear whether third hematopoietic cell transplantation (HCT3) has a place in the treatment of...

    Emily R. Cox, Corinne Summers, ... Monica S. Thakar in Annals of Hematology
    Article 14 July 2024
  7. Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1

    Rosai–Dorfman–Destombes disease (RDD) is a rare histiocytosis characterized by accumulation of S100 + , CD68 + , and CD1a- histiocytes, with...

    Yuichi Taneyama, Akira Morimoto, ... Sana Yokoi in International Journal of Hematology
    Article 14 July 2024
  8. Deep learning model based on endoscopic images predicting treatment response in locally advanced rectal cancer undergo neoadjuvant chemoradiotherapy: a multicenter study

    Purpose

    Neoadjuvant chemoradiotherapy has been the standard practice for patients with locally advanced rectal cancer. However, the treatment response...

    Junhao Zhang, Ruiqing Liu, ... Yun Lu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  9. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition

    SF3B1 mutations frequently occur in cancer yet lack targeted therapies. Clinical trials of XPO1 inhibitors, selinexor and eltanexor, in high-risk...

    Sana Chaudhry, Felipe Beckedorff, ... Justin Taylor in Leukemia
    Article Open access 13 July 2024
  10. An update to experimental and clinical aspects of tumor-associated macrophages in cancer development: hopes and pitfalls

    Tumor-associated macrophages (TAMs) represent one of the most abundant tumor-infiltrating stromal cells, and their normal function in tumor...

    Arash Salmaninejad, Sepideh Mehrpour Layeghi, ... Meysam Yousefi in Clinical and Experimental Medicine
    Article Open access 13 July 2024
  11. Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs

    In the realm of acute respiratory infections, coronavirus disease-19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2...

    **angrong Ye, Ye Li, ... Yifeng Luo in Clinical and Experimental Medicine
    Article Open access 13 July 2024
  12. Targeting the pancreatic tumor microenvironment by plant-derived products and their nanoformulations

    Pancreatic cancer remains a significant health issue with limited treatment options. The tumor stroma, a complex environment made up of different...

    Mohamed J. Saadh, Mohammed Ahmed Mustafa, ... Munther Kadhim Abosaoda in Medical Oncology
    Article 13 July 2024
  13. Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma

    The interaction between stromal and tumor cells in tumor microenvironment is a crucial factor in Mantle cell lymphoma (MCL) progression and therapy...

    Udita **dal, Mukesh Mamgain, ... Neeraj Jain in Leukemia
    Article 13 July 2024
  14. Rare tumours of the pancreas: monocentric study

    Purpose

    The biology of rare pancreatic tumours, which differs from that of ductal pancreatic cancer, requires increased attention. Although the...

    Astrid Bauschke, Annelore Altendorf-Hofmann, ... Utz Settmacher in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  15. Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma

    Background & aims

    Patients with intrahepatic cholangiocarcinoma (iCCA) respond poorly to immune checkpoint blockades (ICBs). In this study, we aimed...

    Bao-Ye Sun, Dai Zhang, ... Shuang-Jian Qiu in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  16. Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia

    Knowledge of the molecular pathogenesis of acute myeloid leukemia has advanced in recent years. Despite novel treatment options, acute myeloid...

    Ramya Nair, Alejandro Salinas-Illarena, ... Hanna-Mari Baldauf in Clinical and Experimental Medicine
    Article Open access 13 July 2024
  17. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway

    Purpose

    Long noncoding RNAs (lncRNAs) exert a significant influence on various cancer-related processes through their intricate interactions with...

    Baoyang Luo, Lin Zhuang, ... Haisheng Fang in Journal of Cancer Research and Clinical Oncology
    Article Open access 13 July 2024
  18. Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases

    Mitotic catastrophe (MC), which occurs under dysregulated mitosis, represents a fascinating tactic to specifically eradicate tumor cells. Whether...

    Zhan-Li Chen, Chen **e, ... Shi-Mei Zhuang in Signal Transduction and Targeted Therapy
    Article Open access 12 July 2024
Did you find what you were looking for? Share feedback.